Furthermore, we analyzed clinicopathological parameters and found that lower expression of CPS1 in IHCCs was prominently related to more advanced primary tumor (pT1, pT2 and pT3) with statistical significance (Figure 2, p = 0.003). Here, CPS1 is linked to neoplasm.